ask="13.95"
ask_size="100"
average_daily_volume="1877750"
bid="10.00"
bid_size="600"
book_value="-0.09"
change="+0.46"
change_from_200_day_moving_average="2.11"
change_from_50_day_moving_average="1.33"
change_from_52_week_high="-1.02"
change_From_52_week_low="5.84"
change_in_percent="+3.57%"
close="13.36"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.56"
ebitda="-52.95M"
eps_estimate_current_year="-0.98"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="-0.84"
ex_dividend_date="N/A"
float_shares="94803000"
high="13.96"
high_52_weeks="14.38"
last_trade_date="3/2/2017"
last_trade_price="13.36"
last_trade_size="188335"
last_trade_time="4:00pm"
low="12.61"
low_52_weeks="7.52"
market_capitalization="1.71B"
moving_average_200_day="11.25"
moving_average_50_day="12.03"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="14.68"
open="12.88"
pe_ratio="N/A"
peg_ratio="0.32"
percent_change_from_200_day_moving_average="+18.73%"
percent_change_from_50_day_moving_average="+11.02%"
percent_change_from_52_week_high="-7.09%"
percent_change_from_52_week_low="+77.66%"
previous_close="12.90"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="10.34"
revenue="159.91M"
shares_outstanding="128154000"
short_ratio="8.07"
stock_exchange="NMS"
symbol="HALO"
volume="2394529"
weeks_range_52="7.52 - 14.38"
